Selected article for: "adequate treatment and long term treatment"
Author: Bénézit, François; Le Bot, Audrey; Jouneau, Stéphane; Lemaître, Florian; Pronier, Charlotte; Lentz, Pierre-Axel; Patrat-Delon, Solène; Revest, Matthieu; Thibault, Vincent; Tattevin, Pierre
Title: COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
  • Cord-id: 5moean7z
  • Document date: 2020_10_25
    • ID: 5moean7z
    Snippet: Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations.
    Document: Because of in vitro studies, hydroxychloroquine has been evaluated as a preexposure or postexposure prophylaxis for coronavirus disease (COVID-19) and as a possible COVID-19 curative treatment. We report a case of COVID-19 in a patient with sarcoidosis who was receiving long-term hydroxychloroquine treatment and contracted COVID-19 despite adequate plasma concentrations.

    Search related documents:
    Co phrase search for related documents
    • admission day and long term treatment: 1, 2, 3, 4
    • admission day and low grade fever: 1, 2, 3, 4
    • admission day and lung auscultation: 1, 2, 3
    • admission day and lung obtain: 1
    • admission day and lupus erythematosus: 1
    • long term hydroxychloroquine treatment and lupus erythematosus: 1
    • long term treatment and lupus erythematosus: 1, 2
    • lung auscultation and lupus erythematosus: 1